arrow
S

Sarah J. Lord

University of Sydney
H指数:43
被引数:9,481

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical impact of TP53 classifications in previously treated advanced driver-negative non-small cell lung cancer: A biomarker analysis of the OAK and POPLAR randomized clinical trials

TP53分类在先前接受过治疗的晚期驱动基因阴性非小细胞肺癌中的临床影响:OAK和POPLAR随机临床试验的生物标志物分析

2025-12-290
OAAI
Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation

这个测试适合目的吗?在体外诊断 (IVD) 法规的新时代中评估测试临床性能的原则和清单

2025-02-060
OA
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

BRCA突变和铂敏感复发性卵巢癌患者接受olaparib维持治疗后对化疗有反应的无进展生存期的预后列线图

2021-09-018
OAAI